Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study
Tae-Seok Lim, Jae-Seung Yun, Seon-Ah Cha, Ki-Ho Song, Ki-Dong Yoo, Yu-Bae Ahn, Yong-Moon Park, Seung-Hyun Ko
Korean J Intern Med. 2016;31(6):1110-1119.   Published online 2016 Oct 18     DOI: https://doi.org/10.3904/kjim.2016.030
Citations to this article as recorded by Crossref logo
Clinical investigation of lipoprotein (a) levels in type 2 diabetics for cardiovascular diseases prediction and prognosis
Yasser Bustanji, Noor Barham, Eman Y. Abu-rish, Abdelkareem Alhyari, Basil Albustanji, Majd Alnajjar, Bashaer Abu-irmaileh, Waseem El-Huneidi, Eman Abu-Gharbieh, Mohammad Mohammad, Mohammed Fararjeh, Ala Issa, Mohammad Semreen, Hana Bajes
Hormone Molecular Biology and Clinical Investigation.2022; 43(3): 263.     CrossRef
Association of C-peptide and lipoprotein(a) as two predictors with cardiometabolic biomarkers in patients with type 2 diabetes in KERCADR population-based study
Mohammad Reza Mahmoodi, Hamid Najafipour, Kanhaiya Singh
PLOS ONE.2022; 17(5): e0268927.     CrossRef
Lipoprotein (a) Levels and Abdominal Aortic Aneurysm. A Systematic Review and Meta-analysis
Stamatios Lampsas, Evangelos Oikonomou, Panteleimon Pantelidis, Panagiotis Theofilis, Konstantinos Grammatopoulos, Anastasios Marathonitis, Michael A Vavuranakis, Gerasimos Siasos, Dimitris Tousoulis, Manolis Vavuranakis
Current Pharmaceutical Design.2022; 28(43): 3492.     CrossRef
High lipoprotein(a) concentrations are associated with lower type 2 diabetes risk in the Chinese Han population: a large retrospective cohort study
Qingan Fu, Lijuan Hu, Yuan Xu, Yingping Yi, Long Jiang
Lipids in Health and Disease.2021;[Epub]     CrossRef
Lipoprotein(a) Concentrations Correlate With LDL-C in Children With Type 1 and 2 Diabetes
Christy Foster, A K M Fazlur Rahman, Ambika P Ashraf
Journal of the Endocrine Society.2021;[Epub]     CrossRef
Mild Malnutrition Contributes the Greatest to the Poor Prognosis in Coronary Artery Disease With Well-Controlled Low-Density Lipoprotein Cholesterol Levels: A 4,863 Chinese Cohort Study
Bo Wang, Zhaodong Guo, Jin Liu, Huanqiang Li, Ziling Mai, Feng Lin, Ming Ying, Yaren Yu, Shiqun Chen, Qiang Li, Haozhang Huang, Wen Wei, Yongquan Yang, Shaohong Dong, Yingling Zhou, Jiyan Chen, Ning Tan, Yong Liu
Frontiers in Nutrition.2021;[Epub]     CrossRef
Effect of Niacin on Carotid Atherosclerosis in Patients at Low-Density Lipoprotein-Cholesterol Goal but High Lipoprotein (a) Level: a 2-Year Follow-Up Study
Shinjeong Song, Chan Joo Lee, Jaewon Oh, Sungha Park, Seok-Min Kang, Sang-Hak Lee
Journal of Lipid and Atherosclerosis.2019; 8(1): 58.     CrossRef
Association Between Lipoprotein(a) and Risk Factors of Atherosclerosis in Russian Population (Data of Observational ESSE-RF study)
S. A. Shalnova, M. V. Ezhov, V. A. Metelskaya, S. E. Evstifeeva, V. I. Tarasov, G. A. Muromtseva, Yu. A. Balanova, A. E. Imaeva, A. V. Kapustina, A. A. Shabunova, O. A. Belova, I. A. Trubacheva, A. Y. Efanov, Z. T. Astakhova, N. V. Kulakova, S. A. Boytsov
Rational Pharmacotherapy in Cardiology.2019; 15(5): 612.     CrossRef
Is a Previously or Currently Reduced Testosterone Level in Male Patients with Type 2 Diabetes Mellitus a Risk Factor for the Development of Coronary Artery Disease? A Systematic Review and Meta-analysis
Feng Huang
Diabetes Therapy.2018; 9(3): 1061.     CrossRef
Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus
H.-W. Zhang, X. Zhao, Y.-L. Guo, Y. Gao, C.-G. Zhu, N.-Q. Wu, J.-J. Li
Nutrition, Metabolism and Cardiovascular Diseases.2018; 28(10): 980.     CrossRef
ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels
Ji Eun Jun, Young Ju Choi, Yong-Ho Lee, Dae Jung Kim, Seok Won Park, Byung Wook Huh, Eun Jig Lee, Sun-Ha Jee, Kyu Yeon Hur, Sung Hee Choi, Kap Bum Huh
The Korean Journal of Internal Medicine.2018; 33(1): 138.     CrossRef
The mixed benefit of low lipoprotein(a) in type 2 diabetes
Michel P. Hermans, Sylvie A. Ahn, Michel F. Rousseau
Lipids in Health and Disease.2017;[Epub]     CrossRef